Sg Americas Securities, LLC Mustang Bio, Inc. Transaction History

Sg Americas Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$0.58 - $1.13 $6,692 - $13,039	-11,539 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$0.73 - $1.81 $6,145 - $15,238	-8,419 Reduced 42.18%	11,539 $12,000
Q4 2021 Feb 07, 2022	SELL	$1.66 - $2.64 $35,990 - $57,237	-21,681 Reduced 52.07%	19,958 $33,000
Q3 2021 Nov 01, 2021	BUY	$2.58 - $3.36 $107,428 - $139,907	41,639 New	41,639 $112,000
Q3 2020 Nov 09, 2020	SELL	$3.01 - $3.88 $46,859 - $60,403	-15,568 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$2.33 - $4.6 $12,395 - $24,471	5,320 Added 51.91%	15,568 $50,000
Q1 2020 Apr 30, 2020	BUY	$1.91 - $4.52 $19,573 - $46,320	10,248 New	10,248 $27,000
Q1 2019 Apr 29, 2019	SELL	$2.95 - $5.61 $36,751 - $69,889	-12,458 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$2.3 - $5.78 $28,653 - $72,007	12,458 New	12,458 $37,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.